Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George A Fritsma

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Seminars in Thrombosis and Hemostasis|May 2, 2009
Whole blood platelet aggregometry and platelet function testingDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2015
Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic populationDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2008
Comparison of four laboratory methods to assess aspirin sensitivityDavid L McGlasson, George A Fritsma
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2017
Whole Blood Platelet AggregometryGeorge A Fritsma, David L McGlasson
Seminars in Thrombosis and Hemostasis|March 8, 2013
Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kitsDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 30, 2011
Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individualsDavid L McGlasson, Anand D Shah, George A Fritsma
American Journal of Clinical Pathology|December 16, 2003
Clinical pathology consultation improves coagulation factor utilization in hospitalized adultsMarisa B Marques, George A Fritsma, J Alan Long, et al.
American Journal of Clinical Pathology|May 16, 2012
Recommendations for appropriate activated partial thromboplastin time reagent selection and utilizationGeorge A Fritsma, Francine R Dembitzer, Ankush Randhawa, et al.
American Journal of Clinical Pathology|January 11, 2003
The effect of lupus anticoagulant in the second-generation assay for activated protein C resistanceBrian D Ragland, Cari E Reed, Barbara M Eiland, et al.
American Journal of Clinical Pathology|February 21, 2008
Screening with the activated protein C resistance assay yields significant savings in a patient population with low prevalence of factor V leidenLaura J Taylor, Robert A Oster, George A Fritsma, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Seminars in Thrombosis and Hemostasis|May 2, 2009
Whole blood platelet aggregometry and platelet function testingDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2015
Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic populationDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 16, 2008
Comparison of four laboratory methods to assess aspirin sensitivityDavid L McGlasson, George A Fritsma
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2017
Whole Blood Platelet AggregometryGeorge A Fritsma, David L McGlasson
Seminars in Thrombosis and Hemostasis|March 8, 2013
Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kitsDavid L McGlasson, George A Fritsma
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 30, 2011
Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individualsDavid L McGlasson, Anand D Shah, George A Fritsma
American Journal of Clinical Pathology|December 16, 2003
Clinical pathology consultation improves coagulation factor utilization in hospitalized adultsMarisa B Marques, George A Fritsma, J Alan Long, et al.
American Journal of Clinical Pathology|May 16, 2012
Recommendations for appropriate activated partial thromboplastin time reagent selection and utilizationGeorge A Fritsma, Francine R Dembitzer, Ankush Randhawa, et al.
American Journal of Clinical Pathology|January 11, 2003
The effect of lupus anticoagulant in the second-generation assay for activated protein C resistanceBrian D Ragland, Cari E Reed, Barbara M Eiland, et al.
American Journal of Clinical Pathology|February 21, 2008
Screening with the activated protein C resistance assay yields significant savings in a patient population with low prevalence of factor V leidenLaura J Taylor, Robert A Oster, George A Fritsma, et al.
Pageof 1